Clinical Trials in El Segundo, California
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
NSCLC Stage IV
ImmunityBio, Inc.507 enrolled19 locationsNCT06745908
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
PDAC - Pancreatic Ductal AdenocarcinomaPancreatic Cancer Metastatic
Engeneic Pty Limited144 enrolled4 locationsNCT07049055
Recruiting
Phase 2
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
Glioblastoma
ImmunityBio, Inc.34 enrolled4 locationsNCT06061809
Recruiting
Phase 2
A Study to Examine Anktiva for the Treatment of COVID-19.
Long COVIDLong COVID SyndromeLong Covid 19
ImmunityBio, Inc.40 enrolled1 locationNCT07123727
Recruiting
Phase 2
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
Platinum Resistant Ovarian Cancer
ImmunityBio, Inc.20 enrolled2 locationsNCT06710288
Recruiting
Phase 1Phase 2
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
Solid Tumor
Alyssum Therapeutics85 enrolled7 locationsNCT06234098